NIH proposes requiring trials to share plain-language results with participants

The National Institutes of Health has issued a draft policy that would require researchers and institutions to share plain-language summaries of study results with people who take part in NIH-supported clinical research, and is seeking public comment on it [s1]. The agency published the request for information in the Federal Register on 25 September 2026, with comments due by 26 October 2026 [s1].

The proposed NIH Policy on Sharing Summary Level Study Results with Clinical Research Participants would, in the agency's words, establish a requirement for researchers and institutions to responsibly share summary level study results with participants in plain language, unless justifiably not appropriate, across all NIH-supported clinical research [s1].

What would be shared, and with whom

The policy targets summary level results, also called aggregate results, which the draft defines as concise overviews of a study after all data are compiled and analysed, covering the objective, methodology, cumulative outcomes or key findings, relevance, limitations and potential implications [s1]. These are distinct from individual research results specific to one participant, such as a person's own laboratory values [s1].

The draft frames the change as a matter of returning value to the people who make research possible. Returning research results, it notes, was identified by the NIH Novel and Exceptional Technology and Research Advisory Committee as one important strategy for returning value to participants [s2]. Sharing results, the agency argues, can build trust between researchers and participants, improve recruitment and retention, and help ensure findings are meaningful and understandable to patients and clinicians [s1].

How broadly it would apply

The scope is wide. As drafted, the policy would apply to all clinical research, including clinical trials, supported in whole or in part by NIH, regardless of the funding level or mechanism, and including the agency's own Intramural Research Program [s1]. It would attach to competing award applications, competitive revisions, new clinical research contracts or orders, and other funding agreements received on or after a date six months from publication of a final policy, and to intramural projects conducted on or after that same point [s1].

Compliance would be built into the terms and conditions of awards and agreements [s1]. Failure to comply, the draft states, may provide a basis for enforcement actions up to and including termination, consistent with grant regulations and NIH policies, and may affect future funding decisions for the recipient institution [s1].

Where it fits among existing rules

The NIH already has several transparency requirements, but the draft notes they have largely focused on sharing information with the scientific community rather than directly with participants [s1]. Researchers must plan how they will make scientific data available under the NIH Policy for Data Management and Sharing; clinical trials must report results on ClinicalTrials.gov under the policy on dissemination of NIH-funded clinical trial information; and published papers are made accessible under the NIH Public Access Policy [s1]. The agency says inconsistency in whether and how results reach participants themselves leaves a significant gap this policy is meant to close [s1].

The draft positions the policy as support for the Department of Health and Human Services' Operation TrialBlazer initiative, which seeks to strengthen US leadership in clinical research [s1]. To develop the draft, the NIH says it gathered stakeholder input in spring 2026 through a public listening session and an on-demand portal for written comment [s1].

What is settled and what is not

What is fixed is that the NIH has published a draft policy and a comment deadline of 26 October 2026 [s1]. What is not settled is the content of the final policy, including the exact requirements for what a summary must contain and how and when it must be shared, which the agency says it will shape using the comments it receives [s1]. The draft also flags that it intends to provide supplemental materials to help the research community, and that some participants may need additional support where summary results raise more questions than they answer [s1]. The requirement would not take effect until six months after a final policy is published [s1].

Sources

• [s1] Draft NIH Policy on Sharing Summary Level Study Results With Clinical Research Participants — National Institutes of Health / Federal Register, 25 September 2026.
• [s2] NExTRAC ENGAGE Report — NIH Novel and Exceptional Technology and Research Advisory Committee, December 2025.